1-39 of 39
Keywords: neurodegeneration
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Articles
Biochem J (2024) 481 (6): 461–480.
Published: 18 March 2024
... in MJD and also appears to be involved in cancer. As aberrant deubiquitination has been linked to both neurodegeneration and cancer, a comprehensive understanding of ataxin-3's DUB function is important for elucidating potential therapeutic targets in these complex conditions. In this review, we aim...
Articles
Biochem J (2024) 481 (3): 141–160.
Published: 29 January 2024
... and mice similarly result in neurodegeneration, CSP is evidently an evolutionarily conserved neuroprotective protein. However, the client proteins that CSP chaperones to prevent neurodegeneration remain unclear. Traditional methods for identifying protein–protein interactions, such as yeast 2-hybrid...
Includes: Supplementary data
Articles
Biochem J (2023) 480 (19): 1485–1501.
Published: 04 October 2023
... CJD (vCJD) in humans [ 12 , 13 ]. Consequently, there is a heightened interest in the monitoring and management of animal prion diseases in order to protect human health. cervid CWD Drosophila melanogaster infectivity neurodegeneration prion © 2023 The Author(s) 2023...
Articles
In Collection
Cell death and survival
Biochem J (2022) 479 (1): 75–90.
Published: 14 January 2022
... and neurodegeneration. As previously mentioned, autophagy generally comes first as a response mechanism to salvage stressed cells from death. When stress exceeds a critical limit and the resulted damage cannot be resolved, ‘suicide' programs are activated and the cell dies. A considerable amount of evidence during...
Articles
Biochem J (2021) 478 (14): 2945–2951.
Published: 30 July 2021
... access for this article was enabled by the participation of University College London in an all-inclusive Read & Publish pilot with Portland Press and the Biochemical Society under a transformative agreement with JISC. leucine-rich repeat kinase neurodegeneration Parkinson's disease...
Articles
Biochem J (2021) 478 (14): 2733–2758.
Published: 23 July 2021
... proposed as a potential strategy to slow down the progression of neurodegeneration. Through the development and application of tools that allow dissection of the mechanistic roles of this PTM, there is now a growing body of evidence that O -GlcNAc influences a variety of important neurodegeneration...
Articles
Biochem J (2021) 478 (10): 1959–1976.
Published: 28 May 2021
... diseases, with a comparative focus on Alzheimer's disease and Parkinson's disease. © 2021 The Author(s). Published by Portland Press Limited on behalf of the Biochemical Society 2021 amphisome autophagy late endosome neurodegeneration neurotrophic signaling retrograde axonal transport...
Articles
Biochem J (2020) 477 (4): 833–852.
Published: 28 February 2020
.... These studies highlight the use of PrP transgenic Drosophila as a genetically well-defined tractable host to study mammalian prion biology. Drosophila melanogaster neurodegeneration prion transcriptomics Protein misfolding neurodegenerative diseases are invariably fatal conditions that include...
Includes: Supplementary data
Articles
Biochem J (2019) 476 (22): 3493–3504.
Published: 27 November 2019
...-dependent neurodegeneration, where astrocytes lose key molecules involved in regulation of glutamate/glutamine homeostasis, neuronal survival and synaptogenesis. Astrocytic dysfunction in tauopathy appears to precede neurodegeneration and overt tau neuropathology such as phosphorylation, aggregation...
Articles
Biochem J (2019) 476 (5): 859–873.
Published: 12 March 2019
... under redox control and presents a new perspective toward AD pathology. These results also prompt further investigation into the role(s) of other GRNs in AD pathogenesis. Alzheimer's disease amyloid-β cysteine-rich proteins granulin neurodegeneration progranulin Aβ42 monomers were...
Includes: Supplementary data
Articles
Biochem J (2018) 475 (19): 3087–3103.
Published: 10 October 2018
... Aβ42 peptide Alzheimer's disease amyloids neurodegeneration neuronal cell toxicity protein aggregation Among human neurodegenerative diseases, Alzheimer's disease (AD) is the most common, with nearly 47 million patients worldwide [ 1 ]. AD is characterized by a sequestration of amyloid β...
Includes: Supplementary data
Articles
Biochem J (2017) 474 (8): 1417–1438.
Published: 07 April 2017
... RBPs with PrLDs. We also highlight the potential of protein disaggregases, including Hsp104, as a therapeutic strategy to combat the aberrant phase transitions of RBPs with PrLDs that likely underpin neurodegeneration. Correspondence: James Shorter ( [email protected] ) 9 1 2017...
Articles
Biochem J (2017) 474 (3): 333–355.
Published: 20 January 2017
... transport system covers a diverse array of proteins involved in metabolic support, neurotransmission and synaptic architecture. Therefore, specific targeting of individual transporter families has the potential to suppress neurodegeneration, a characteristic hallmark of AD. A small number of the 400...
Articles
Biochem J (2016) 473 (22): 4083–4101.
Published: 10 November 2016
...-ND) . cancer functional genomics neurodegeneration proteomics proteostasis ubiquitin Conjugation of the small protein modifier ubiquitin (Ub) is one of the most abundant post-translational modifications in cellular signalling. Ubiquitylation regulates a wide range of cellular...
Articles
Biochem J (2016) 473 (21): 3871–3888.
Published: 27 October 2016
... with increases in lactate levels and altered Krebs' intermediates, neurotransmitters, markers of neurodegeneration and increases in oxidative stress-mediated damage to biomolecules. The number of CGG repeats correlated with a subset of plasma metabolites, which are implicated not only in mitochondrial disorders...
Includes: Supplementary data
Articles
Biochem J (2016) 473 (11): 1563–1578.
Published: 27 May 2016
... neurodegeneration protein engineering Alzheimer's disease (AD) is the most prevalent form of dementia, with 10% of the human population older than 65 years and 40% older than 85 years affected [ 1 ]. Apart from certain forms of inherited AD [ 2 ], age is the major risk factor associated...
Includes: Supplementary data
Articles
Articles
Biochem J (2014) 462 (3): 489–497.
Published: 22 August 2014
... disease models. apoptosis DJ-1 neurodegeneration neuron receptor of activated C kinase 1 (RACK1) Known as the second most common progressive neurodegenerative disease, PD (Parkinson's disease) is one type of locomotion disorder of the central nervous system and is characterized...
Articles
Biochem J (2014) 462 (1): 67–75.
Published: 24 July 2014
.... The observed movement phenotype may be caused by reduced densities of PV+/ Gad67 (glutamic acid decarboxylase 67)+ GABAergic and ChAT (choline acetyltransferase)+ cholinergic neurons in the striatum. cholinergic glutathione peroxidase neurodegeneration parvalbumin redox selenium SePs...
Includes: Multimedia, Supplementary data
Articles
Biochem J (2014) 460 (2): 141–156.
Published: 13 May 2014
[email protected] ). 5 2 2014 14 3 2014 18 3 2014 © The Authors Journal compilation © 2014 Biochemical Society 2014 cancer casein kinase 1 (CK1) casein kinase 2 (CK2) family with sequence similarity 20C (Fam20C) genuine casein kinase (G-CK) neurodegeneration In the second...
Includes: Supplementary data
Articles
Biochem J (2013) 450 (2): 253–264.
Published: 15 February 2013
... meprin metalloprotease neurodegeneration proteomics Proteolysis is an irreversible post-translational modification that affects every single cell of an organism. Over the last decades proteolytic enzymes have been identified to be master switches in the regulation of the immune system...
Includes: Multimedia, Supplementary data
Articles
Articles
Biochem J (2012) 441 (2): 523–540.
Published: 21 December 2011
... mitochondrion neurodegeneration nitrative stress oxidative stress redox signalling Autophagy (or self-eating) was first described by Christian de Duve in 1963 as a lysosome-mediated degradation process for non-essential or damaged cellular constituents [ 1 , 2 ]. Physiologically, it serves...
Articles
Articles
Articles
Biochem J (2011) 433 (1): 19–29.
Published: 15 December 2010
..., Huntington's and Parkinson's diseases, and the rarer prion diseases, are separate entities clinically but have common features, including aggregates of misfolded proteins and varying patterns of neurodegeneration. A key barrier to effective treatment is that patients present clinically with advanced...
Includes: Supplementary data
Articles
Biochem J (2010) 429 (3): 545–552.
Published: 14 July 2010
... visualized with ECL reagents on a Kodak 2000 MM Imager. Images were analysed with the Kodak Imager 2000 MM software. fragile X-associated tremor/ataxia syndrome (FXTAS) mitochondrion neurodegeneration oxidative stress trinucleotide repeat expansion unfolded protein response FXTAS (fragile X...
Includes: Supplementary data
Articles
Biochem J (2010) 428 (1): 85–93.
Published: 28 April 2010
... [ 7 , 9 ]. The selective loss of neurons in neurodegeneration points to a differential susceptibility between neurons and their surrounding glial cells in the disease process. As such, astrocytes have shown to be more resistant to NO • toxicity than neurons and this has been attributed in part...
Articles
Biochem J (2009) 422 (1): 11–22.
Published: 29 July 2009
... neurodegeneration selenium selenocysteine selenoprotein thyroid hormone The trace element selenium (Se), originally viewed as a toxin, is now understood to be an important micronutrient [ 1 ]. Selenium is incorporated into proteins not simply though ionic association, as most metals...
Includes: Multimedia, Supplementary data
Articles
Articles
Biochem J (2005) 392 (3): 675–683.
Published: 06 December 2005
...Judit Oláh; Ferenc Orosz; László G. Puskás; László Hackler, Jr; Margit Horányi; László Polgár; Susan Hollán; Judit Ovádi Triosephosphate isomerase (TPI) deficiency is a unique glycolytic enzymopathy coupled with neurodegeneration. Two Hungarian compound heterozygote brothers inherited the same TPI...
Includes: Supplementary data
Articles
Biochem J (2005) 386 (2): E5.
Published: 22 February 2005
... neurodegeneration selenium selenium transport selenoprotein selenoprotein P Selenium (Se) is an essential micronutrient that is required in a variety of metabolic functions that includes its role in antioxidant defences (for a review see [ 1 ]). Se is incorporated into an interesting class of molecules...
Articles
Biochem J (2004) 383 (1): 121–128.
Published: 24 September 2004
... neurodegeneration permeability transition respiratory chain synaptosome According to the metabolic control theory [ 36 , 37 ], the flux control coefficient of AAC ( C AAC ) in phosphorylating mitochondria can be defined as the fractional change in respiration (dJO 2 ) in proportion to the fractional change...
Articles
Articles
Biochem J (2003) 372 (1): 129–136.
Published: 15 May 2003
... for this neurodegeneration. The PrP 106–126, a synthetic peptide obtained from the amyloidogenic region of the PrP, constitutes a model system to study prion-induced neurodegeneration as it retains the ability to trigger cell death in neuronal cultures. In the present study, we show that the addition of this prion peptide...
Articles
Biochem J (2002) 362 (2): 253–258.
Published: 22 February 2002
... correspondence should be addressed (e-mail [email protected] ). 11 9 2001 12 11 2001 12 12 2001 The Biochemical Society, London ©2002 2002 copper manganese neurodegeneration scrapie superoxide Abbreviations used: BCA, bicinchoninic acid; NBT, Nitro Blue Tetrazolium; PrP...
Articles
Biochem J (2002) 362 (2): 459–464.
Published: 22 February 2002
... was slow (2 h). It is concluded that NO is consumed in the brain through a novel protein, ultimately forming NO $ , and that the slow regeneration of the activity provides a scenario for NO to become toxic. Key words: cGMP, neurodegeneration, respiration. The brain is particularly enriched...
Articles
Biochem J (2001) 359 (1): 1–16.
Published: 24 September 2001
...: cancer, diabetes, insulin, neurodegeneration, Wnt. Akt) [9]. Subsequent work has elucidated the phosphatidyl- inositide (PI) 3-kinase-dependent pathway by which PKB is activated by insulin (Figure 1; for reviews, see [10,11 Thus, in response to insulin, the inhibition of GSK3 promotes...
Articles
Biochem J (1999) 344 (3): 625–631.
Published: 08 December 1999
... residue, and it is suggested that this may cause a toxic gain of function in NTE. The Biochemical Society, London © 1999 1999 active site gain of function neural development neurodegeneration protein family Biochem. J. (1999) 344, 625 631 (Printed in Great Britain) 625 REVIEW ARTICLE...